Braveheart Bio
PrivateLast Round
Series A
Nov 5, 2025
Total Funding Raised
$185M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Braveheart Bio is a biotechnology company developing novel therapeutics for hypertrophic cardiomyopathy and related cardiovascular conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Braveheart Bio Comparables
Compare Braveheart Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sanofi | 80% | |
| Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 78% | |
| Cytokinetics, Incorporated | 77% | |
Braveheart Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 5, 2025 |
Key People
Founding team and executive leadership
Braveheart Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series A |
| Enavate Sciences | Series A |
| Forbion | Series A |
| OrbiMed | Series A |
| Frazier Life Sciences | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 18, 2026
Grew 44% QoQ, from 27 to 39 employees.
- Jun 30, 2026
Grew 33% QoQ, from 27 to 36 employees.
Braveheart Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Braveheart Bio's valuation, stock price, and market status.